Aquatic Capital Management LLC Stoke Therapeutics, Inc. Transaction History

Aquatic Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.12 - $14.17 $39,552 - $136,032	9,600 New	9,600 $129,000
Q4 2022 Feb 14, 2023	SELL	$7.07 - $15.69 $53,732 - $119,244	-7,600 Reduced 98.7%	100 $1,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $71,592 - $128,421	5,700 Added 285.0%	7,700 $99,000
Q2 2022 Aug 15, 2022	BUY	$10.36 - $23.93 $8,288 - $19,144	800 Added 66.67%	2,000 $26,000
Q1 2022 May 16, 2022	SELL	$17.19 - $26.1 $1,719 - $2,610	-100 Reduced 7.69%	1,200 $25,000
Q4 2021 Feb 14, 2022	BUY	$18.11 - $30.72 $23,543 - $39,936	1,300 New	1,300 $31,000

117

55.6M

14K

8.8K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $482M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.